April 30, 2026 • Sen. Lisa Murkowski says Congress needs to assert itself with the Trump administration on its war with Iran. Also, Alaska Native artists decry the online marketplace Etsy's ban on ...

When opportunity knocks, open the door. For Secretary of State William H. Seward, opportunity literally arrived with a knock on the door. On the evening of March 29, 1867, the Russian minister to the ...

Vikki Velasquez is a researcher and writer who has managed, coordinated, and directed various community and nonprofit organizations. She has conducted in-depth research on social and economic issues ...

Lauren Dana Ellman is a New York-based writer and editor who specializes in travel, lifestyle, food, and shopping content. Thanks to the abundance of onboard activities and amenities, Norwegian Cruise ...

Written by: Anupam Agarwal, M.D. The past month saw the culmination of years of planning and construction with the official openings of the Altec/Styslinger Genomic Medicine and Data Sciences Building ...

JUNEAU, Alaska — The Trump administration on Thursday finalized plans to open the coastal plain of Alaska's Arctic National Wildlife Refuge to potential oil and gas drilling, renewing a long-simmering ...

NORWALK, Conn., Oct. 9, 2025 /PRNewswire/ -- Lifespan Vision Ventures congratulates its portfolio company, Algen Biotechnologies, on the announcement of its multi-target research collaboration with ...

Algen Biotechnologies and AstraZeneca collaborate to advance immunology therapies using the AlgenBrain platform, with Algen receiving up to $555 million in milestone payments. AlgenBrain leverages AI ...

(Reuters) -AstraZeneca has signed a $555 million deal with a San Francisco-based biotech business Algen Biotechnologies, The Financial Times reported on Monday. The agreement with Algen gives ...

Algen Biotechnologies said on Monday it had agreed to grant AstraZeneca a license to develop therapies the U.S.-based biotech discover using its AI-driven gene-editing platform, in a deal worth up to ...

AstraZeneca signs up to $555 million AI deal with Algen to develop therapies Algen Biotechnologies said on Monday it had agreed to grant AstraZeneca a license to develop therapies the U.S.-based ...